"outcomeCategory","disease","timeWindow","MPCD AS cohort","Marketscan AS cohort","Medicare AS cohort"
"Cancer","Hematologic Cancer","12 months","0.2 (0.1-0.7)","0.3 (0.2-0.5)","1.0 (0.8-1.2)"
"Cancer","Hematologic Cancer","24 months","0.5 (0.2-1.0)","0.5 (0.3-0.7)","1.4 (1.1-1.7)"
"Cancer","Hematologic Cancer","36 months","0.7 (0.3-1.2)","0.5 (0.4-0.8)","1.6 (1.3-2.0)"
"Cancer","Hematologic Cancer","AS cohort entry to exposure","0.7 (0.3-1.2)","0.2 (0.1-0.4)","1.0 (0.8-1.3)"
"Cancer","Non Melanoma Skin Cancer","12 months","0","0.6 (0.4-0.8)","0.9 (0.7-1.2)"
"Cancer","Non Melanoma Skin Cancer","24 months","0","1.1 (0.9-1.4)","1.5 (1.2-1.8)"
"Cancer","Non Melanoma Skin Cancer","36 months","0","1.5 (1.2-1.8)","2.1 (1.8-2.5)"
"Cancer","Non Melanoma Skin Cancer","AS cohort entry to exposure","0","0.7 (0.5-0.9)","0.8 (0.6-1.1)"
"Cancer","Solid Cancer","12 months","3.0 (2.2-4.1)","2.6 (2.2-3.1)","7.6 (7.0-8.3)"
"Cancer","Solid Cancer","24 months","4.7 (3.6-6.0)","3.5 (3.0-4.0)","9.4 (8.7-10.1)"
"Cancer","Solid Cancer","36 months","5.6 (4.4-7.0)","3.9 (3.4-4.5)","11.1 (10.4-11.9)"
"Cancer","Solid Cancer","AS cohort entry to exposure","2.6 (1.8-3.6)","2.7 (2.3-3.2)","7.6 (7.0-8.3)"
"Cardiac disease","Aortic Insufficiency/Aortic Regurgitation","12 months","1.8 (1.2-2.7)","1.1 (0.8-1.4)","3.6 (3.2-4.1)"
"Cardiac disease","Aortic Insufficiency/Aortic Regurgitation","24 months","2.1 (1.4-3.1)","1.3 (1.0-1.7)","5.0 (4.5-5.6)"
"Cardiac disease","Aortic Insufficiency/Aortic Regurgitation","36 months","2.5 (1.8-3.5)","1.5 (1.2-1.8)","6.2 (5.6-6.8)"
"Cardiac disease","Aortic Insufficiency/Aortic Regurgitation","AS cohort entry to exposure","1.4 (0.8-2.2)","1.0 (0.8-1.3)","3.7 (3.3-4.2)"
"Cardiac disease","Conduction Block","12 months","0.4 (0.2-0.9)","0.8 (0.6-1.1)","2.5 (2.1-2.9)"
"Cardiac disease","Conduction Block","24 months","0.7 (0.4-1.3)","1.3 (1.0-1.6)","4.0 (3.5-4.5)"
"Cardiac disease","Conduction Block","36 months","0.7 (0.4-1.3)","1.6 (1.2-1.9)","5.1 (4.6-5.6)"
"Cardiac disease","Conduction Block","AS cohort entry to exposure","0.4 (0.2-0.9)","0.7 (0.5-1.0)","2.9 (2.6-3.4)"
"Cardiac disease","Myocardial infarction","12 months","0.1 (0.0-0.4)","0.2 (0.1-0.3)","0.7 (0.5-0.9)"
"Cardiac disease","Myocardial infarction","24 months","0.3 (0.1-0.8)","0.3 (0.2-0.5)","1.3 (1.0-1.6)"
"Cardiac disease","Myocardial infarction","36 months","0.3 (0.1-0.8)","0.5 (0.3-0.7)","1.7 (1.4-2.1)"
"Cardiac disease","Myocardial infarction","AS cohort entry to exposure","0.2 (0.0-0.5)","0.2 (0.1-0.4)","0.9 (0.7-1.1)"
"Infection","Hospitalized infection","12 months","0.7 (0.3-1.2)","2.6 (2.2-3.1)","6.9 (6.3-7.5)"
"Infection","Hospitalized infection","24 months","1.6 (1.0-2.5)","4.6 (4.0-5.2)","13.3 (12.5-14.2)"
"Infection","Hospitalized infection","36 months","2.2 (1.5-3.1)","5.4 (4.8-6.1)","17.9 (17.0-18.8)"
"Infection","Hospitalized infection","AS cohort entry to exposure","1.4 (0.8-2.2)","3.2 (2.8-3.7)","9.2 (8.6-9.9)"
"Infection","Opportunistic infection","12 months","0.9 (0.5-1.6)","1.0 (0.7-1.3)","2.0 (1.7-2.3)"
"Infection","Opportunistic infection","24 months","1.3 (0.8-2.1)","1.3 (1.1-1.7)","3.2 (2.8-3.6)"
"Infection","Opportunistic infection","36 months","1.6 (1.0-2.5)","1.7 (1.3-2.0)","4.0 (3.5-4.4)"
"Infection","Opportunistic infection","AS cohort entry to exposure","0.7 (0.4-1.3)","0.8 (0.6-1.0)","2.1 (1.8-2.4)"
"Inflammatory bowel disease","Crohn’s Disease","12 months","3.2 (2.3-4.3)","3.5 (3.0-4.0)","5.0 (4.5-5.6)"
"Inflammatory bowel disease","Crohn’s Disease","24 months","4.7 (3.6-6.0)","4.4 (3.9-5.0)","5.9 (5.3-6.5)"
"Inflammatory bowel disease","Crohn’s Disease","36 months","5.3 (4.2-6.7)","4.7 (4.2-5.3)","6.4 (5.8-7.0)"
"Inflammatory bowel disease","Crohn’s Disease","AS cohort entry to exposure","2.8 (2.0-3.8)","3.2 (2.7-3.7)","5.1 (4.6-5.6)"
"Inflammatory bowel disease","Ulcerative Colitis","12 months","2.6 (1.8-3.6)","2.3 (1.9-2.7)","2.5 (2.1-2.9)"
"Inflammatory bowel disease","Ulcerative Colitis","24 months","3.0 (2.2-4.1)","3.0 (2.5-3.5)","3.3 (2.9-3.8)"
"Inflammatory bowel disease","Ulcerative Colitis","36 months","3.3 (2.4-4.4)","3.1 (2.7-3.6)","3.8 (3.4-4.3)"
"Inflammatory bowel disease","Ulcerative Colitis","AS cohort entry to exposure","2.5 (1.7-3.4)","2.2 (1.8-2.6)","2.9 (2.5-3.3)"
"Kidney disease","Amyloidosis","12 months","0.1 (0.0-0.4)","0.0 (0.0-0.1)","0.1 (0.0-0.2)"
"Kidney disease","Amyloidosis","24 months","0.2 (0.0-0.5)","0.1 (0.0-0.2)","0.1 (0.1-0.3)"
"Kidney disease","Amyloidosis","36 months","0.2 (0.1-0.7)","0.1 (0.0-0.2)","0.2 (0.1-0.3)"
"Kidney disease","Amyloidosis","AS cohort entry to exposure","0.1 (0.0-0.4)","0.0 (0.0-0.1)","0.1 (0.0-0.1)"
"Kidney disease","IgA nephropathy","12 months","0.3 (0.1-0.8)","0.2 (0.1-0.3)","0.1 (0.1-0.2)"
"Kidney disease","IgA nephropathy","24 months","0.3 (0.1-0.8)","0.2 (0.1-0.3)","0.2 (0.1-0.4)"
"Kidney disease","IgA nephropathy","36 months","0.5 (0.2-1.0)","0.2 (0.1-0.4)","0.4 (0.2-0.5)"
"Kidney disease","IgA nephropathy","AS cohort entry to exposure","0.2 (0.0-0.5)","0.1 (0.1-0.3)","0.2 (0.1-0.3)"
"Kidney disease","Nephrotic syndrome","12 months","0.1 (0.0-0.4)","0.0 (0.0-0.1)","0.2 (0.1-0.3)"
"Kidney disease","Nephrotic syndrome","24 months","0.2 (0.0-0.5)","0.1 (0.0-0.2)","0.2 (0.1-0.4)"
"Kidney disease","Nephrotic syndrome","36 months","0.2 (0.0-0.5)","0.1 (0.0-0.2)","0.3 (0.2-0.4)"
"Kidney disease","Nephrotic syndrome","AS cohort entry to exposure","0.0 (0.0-0.2)","0.1 (0.0-0.2)","0.1 (0.1-0.2)"
"Lung disease","Apical Pulmonary fibrosis","12 months","0.0 (0.0-0.2)","0","0.0 (0.0-0.1)"
"Lung disease","Apical Pulmonary fibrosis","24 months","0.1 (0.0-0.4)","0","0.0 (0.0-0.1)"
"Lung disease","Apical Pulmonary fibrosis","36 months","0.1 (0.0-0.4)","0","0.0 (0.0-0.1)"
"Lung disease","Apical Pulmonary fibrosis","AS cohort entry to exposure","0.0 (0.0-0.2)","0","0.0 (0.0-0.1)"
"Lung disease","Interstitial lung disease","12 months","0","0.1 (0.0-0.2)","0.3 (0.2-0.5)"
"Lung disease","Interstitial lung disease","24 months","0","0.1 (0.0-0.2)","0.5 (0.4-0.7)"
"Lung disease","Interstitial lung disease","36 months","0","0.1 (0.1-0.3)","0.7 (0.5-0.9)"
"Lung disease","Interstitial lung disease","AS cohort entry to exposure","0","0.0 (0.0-0.1)","0.3 (0.2-0.4)"
"Lung disease","Restrictive lung disease ","12 months","0.8 (0.4-1.4)","0.8 (0.6-1.1)","2.6 (2.2-3.0)"
"Lung disease","Restrictive lung disease ","24 months","1.6 (1.0-2.4)","1.3 (1.0-1.6)","4.2 (3.7-4.7)"
"Lung disease","Restrictive lung disease ","36 months","1.8 (1.2-2.7)","1.5 (1.2-1.8)","5.4 (4.9-6.0)"
"Lung disease","Restrictive lung disease ","AS cohort entry to exposure","0.9 (0.5-1.6)","0.8 (0.6-1.0)","3.1 (2.7-3.5)"
"Neurological Disease","Cauda Equina syndrome","12 months","0.1 (0.0-0.4)","0.0 (0.0-0.1)","0.2 (0.1-0.3)"
"Neurological Disease","Cauda Equina syndrome","24 months","0.2 (0.0-0.5)","0.1 (0.0-0.2)","0.2 (0.1-0.4)"
"Neurological Disease","Cauda Equina syndrome","36 months","0.2 (0.0-0.5)","0.1 (0.0-0.2)","0.3 (0.2-0.4)"
"Neurological Disease","Cauda Equina syndrome","AS cohort entry to exposure","0.2 (0.0-0.5)","0.1 (0.0-0.2)","0.2 (0.1-0.3)"
"Neurological Disease","Spinal Cord compression","12 months","0.1 (0.0-0.4)","0.1 (0.0-0.2)","0.3 (0.2-0.4)"
"Neurological Disease","Spinal Cord compression","24 months","0.2 (0.1-0.7)","0.2 (0.1-0.4)","0.4 (0.3-0.6)"
"Neurological Disease","Spinal Cord compression","36 months","0.3 (0.1-0.8)","0.3 (0.2-0.5)","0.5 (0.3-0.7)"
"Neurological Disease","Spinal Cord compression","AS cohort entry to exposure","0.1 (0.0-0.4)","0.1 (0.0-0.2)","0.4 (0.2-0.5)"
"Osteoporotic fracture","Clinical vertebral fracture","12 months","1.2 (0.7-2.0)","0.7 (0.5-0.9)","2.2 (1.9-2.6)"
"Osteoporotic fracture","Clinical vertebral fracture","24 months","1.6 (1.0-2.5)","1.0 (0.7-1.3)","3.6 (3.2-4.1)"
"Osteoporotic fracture","Clinical vertebral fracture","36 months","2.0 (1.3-2.9)","1.2 (0.9-1.5)","4.7 (4.2-5.3)"
"Osteoporotic fracture","Clinical vertebral fracture","AS cohort entry to exposure","0.9 (0.5-1.6)","0.8 (0.6-1.0)","2.8 (2.5-3.3)"
"Osteoporotic fracture","Non-vertebral osteoporotic fracture","12 months","1.8 (1.2-2.7)","0.9 (0.6-1.1)","2.8 (2.4-3.2)"
"Osteoporotic fracture","Non-vertebral osteoporotic fracture","24 months","3.5 (2.6-4.7)","1.7 (1.3-2.0)","5.2 (4.7-5.7)"
"Osteoporotic fracture","Non-vertebral osteoporotic fracture","36 months","3.9 (2.9-5.1)","2.1 (1.7-2.5)","6.9 (6.3-7.5)"
"Osteoporotic fracture","Non-vertebral osteoporotic fracture","AS cohort entry to exposure","2.6 (1.8-3.6)","1.4 (1.1-1.8)","4.2 (3.7-4.7)"
"PsO/PsA","Psoriasis","12 months","2.0 (1.3-2.9)","3.1 (2.6-3.5)","3.2 (2.8-3.7)"
"PsO/PsA","Psoriasis","24 months","2.9 (2.0-3.9)","4.1 (3.6-4.7)","4.6 (4.1-5.2)"
"PsO/PsA","Psoriasis","36 months","3.5 (2.6-4.7)","4.7 (4.1-5.3)","5.5 (4.9-6.0)"
"PsO/PsA","Psoriasis","AS cohort entry to exposure","1.9 (1.2-2.8)","2.3 (1.9-2.8)","3.6 (3.2-4.1)"
"PsO/PsA","Psoriatic arthritis","12 months","3.3 (2.4-4.4)","3.9 (3.4-4.5)","4.6 (4.1-5.2)"
"PsO/PsA","Psoriatic arthritis","24 months","4.3 (3.3-5.6)","5.3 (4.7-5.9)","6.1 (5.5-6.7)"
"PsO/PsA","Psoriatic arthritis","36 months","5.3 (4.2-6.7)","5.7 (5.1-6.4)","7.0 (6.4-7.6)"
"PsO/PsA","Psoriatic arthritis","AS cohort entry to exposure","2.8 (2.0-3.8)","3.0 (2.6-3.5)","4.4 (3.9-4.9)"
"Uveitis","Uveitis","12 months","8.1 (6.7-9.7)","8.2 (7.5-9.0)","6.9 (6.3-7.5)"
"Uveitis","Uveitis","24 months","10.5 (8.9-12.4)","10.3 (9.5-11.2)","9.0 (8.3-9.7)"
"Uveitis","Uveitis","36 months","11.2 (9.5-13.1)","11.3 (10.5-12.2)","10.6 (9.9-11.4)"
"Uveitis","Uveitis","AS cohort entry to exposure","8.6 (7.1-10.3)","8.7 (8.0-9.5)","7.2 (6.6-7.8)"
